MarketResearchReport2021

  Remdesivir Market Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. According to MRFR analysis, Global  Remdesivir (COVID 19) Market  is expected to register a  CAGR of 31.2%  during the forecast period of 2020 to 2027 and reach  USD 10,119.99 Million by 2027. The growth of the global Remdesivir (COVID 19 )  market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19 ) , are expected to restrain the growth of the global Remdesivir (COVID 19 )  market. Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hu

  AI in Drug Discovery Market In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019. According to MRFR analysis, the Global  AI in Drug Discovery Market   is expected to register a  CAGR of 40.8%  during the forecast period and is anticipated to reach  USD 2,015.1 Million by 2025. The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery. Segment Analysis The report is segmented into seven dynamic

  Cardiac Biomarkers Market The key factors that drive the cardiac biomarkers market are the increasing prevalence of cardiovascular diseases and lifestyle diseases, increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment & research in which cardiac biomarkers are used, technological advancements in cardiac biomarkers, and favorable government initiatives to create awareness related to cardiovascular diseases. However, a lack of awareness among people is expected to hamper market growth. There are a number of factors that impact the growth of the cardiac biomarkers market. Some of the key factors include a rise in demand for diagnostic and testing of various cardiovascular diseases, development and advancement in cardiac biomarkers, and growth in the patient population suffering from cardiovascular diseases. Other key growth drivers include the rise in the number of new cardiovascular cases diagnosed each year and t

  Healthcare Cyber Security Market Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime. The primary vital factors driving the market growth are the increasing cyberattacks in the healthcare industry, regulatory and government norms to protect patient data, and the growing implementation of mobile device applications and platforms and increased use of Internet of things (IoT) devices in the healthcare sector. However, factors such as lack of adoption of updated software and limited awareness about cybersecurity healthcare are likely to hamper the market growth during the forecast period.  Healthcare Cyber Security Market  is expected

  Uveitis Treatment Market Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis. According to MRFR analysis,  Uveitis Treatment Market   is expected to register a  CAGR of 5.6%  during the forecast period and was valued at  USD 534.6 million in 2018 . The growth of the global uveitis treatment market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period. The global uveitis treatment market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collaborations to strengthen their market positio

  Molecular Diagnostics Market The market for molecular diagnostics is set to reach US$16.32 billion by 2025. As per Global Market, the global market is anticipated to witness growth owing to the factors such as technological advancements in molecular diagnostics as well as the increasing prevalence of hospital-acquired infections. However, the market will face challenges and restraints due to the stringency of molecular diagnostics regulations and the restrictive nature of the regulatory framework during the forecast period. The detection of numerous diseases in the market is set to play a key role in determining the growth potential during 2016 to 2025 years. Analysts have also studied the molecular diagnostics industry to understand potential threats and challenges the molecular diagnostics industry companies could face. Although the molecular diagnostics industry is poised to grow at a fast pace across application, end user, product, and technique segments, factors such as the stri

  Insulin Pumps Market The market for insulin pumps is set to reach US$8,520.9 million by 2023. The global market is anticipated to witness growth owing to the factors such as growing prevalence of diabetes as well as the increasing awareness about the disease . However, the market will face challenges and restraints due to expenses associated with insulin and the rise in insulin cost during the forecast period. The global  Insulin Pumps Market , during the forecast period, will register growth at a  CAGR of 8.4%. The growing development activities in the market is set to play a key role in determining the growth potential during forecast year. Analysts have also studied the market to understand potential threats and challenges the insulin pumps market companies could face. Although the market is poised to grow at a fast pace across type, accessories, end-users, and applications segments, factors such as the growing inclination towards naturopathy could slow down the insulin pumps mark